Multi-echo Susceptibility-Based imaging (SBI)
Showing 1 - 25 of >10,000
Scan-rescan Reproducibility of Myelin Sensitive MRI Techniques
Completed
- Myelin Integrity
- myelin sensitive MRI scan
-
Basel, SwitzerlandNeurologische Klinik und Poliklinik, University Hospital Basel
Dec 14, 2021
Imaging Interplay Between Axonal Damage and Repair in Multiple
Recruiting
- Multiple Sclerosis (MS)
- +3 more
- MRI
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Neurology
Dec 15, 2021
Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)
Recruiting
- Brain Diseases
- Low-dose GBCA levels
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Mar 2, 2023
3D Free-Breathing Multi-echo Acquisition for Whole-body
Withdrawn
- Healthy Volunteer
- (no location specified)
May 26, 2022
MRI Trial in United States (STrategically Acquired Gradient Echo (STAGE))
Completed
- MRI
- STrategically Acquired Gradient Echo (STAGE)
-
Loma Linda, California
- +4 more
Jun 2, 2022
Brain Metastases, Radiosurgery Trial in Seoul (Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling
Not yet recruiting
- Brain Metastases
- Radiosurgery
- Magnetic resonance imaging (MRI)
- +3 more
-
Seoul, Korea, Republic ofAsan Medical Center
May 11, 2023
Discover Gene-microenvironment Interactions in
Recruiting
- Attention-Deficit Hyperactivity Disorder, Unspecified Type
- Autism Spectrum Disorder
- ASD diagnosis
- Psychiatric diagnosis
-
Taipei, TaiwanNational Taiwan Univeristy Hospital
Sep 23, 2022
Emphysema Trial in Pessac (MR and CT measurements of emphysema quantification)
Completed
- Emphysema
- MR and CT measurements of emphysema quantification
-
Pessac, FranceUniversity Hospital Bordeaux
Feb 8, 2022
Cardiac Disease Trial in Pessac (Cardiac MRI acquisition)
Not yet recruiting
- Cardiac Disease
- Cardiac MRI acquisition
-
Pessac, FranceChu de Bordeaux
May 23, 2023
Brain Tumor, Brain Metastases Trial in Toronto (Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI))
Recruiting
- Brain Tumor
- Brain Metastases
- Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)
-
Toronto, Ontario, CanadaUniversity Health Network
May 2, 2022
Liver Tumor Trial in Cincinnati (RFA controlled using echo decorrelation imaging, RFA controlled using standard
Recruiting
- Liver Tumor
- RFA controlled using echo decorrelation imaging
- RFA controlled using standard manufacturer-specified algorithms
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jul 12, 2022
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine
Not yet recruiting
- Demyelinating Diseases
- +4 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023
Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor Trial (pH Measurement of in vivo tissue)
Not yet recruiting
- Glioblastoma Multiforme
- +2 more
- pH Measurement of in vivo tissue
- (no location specified)
Sep 26, 2023
Sturge-Weber Syndrome Trial in Detroit (Brain magnetic resonance imaging, Neuro-psychology testing)
Recruiting
- Sturge-Weber Syndrome
- Brain magnetic resonance imaging
- Neuro-psychology testing
-
Detroit, MichiganWayne State University / Children's Hospital of Michigan
Jan 5, 2022
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco
Not yet recruiting
- Multiple Sclerosis (MS)
- +6 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023
An Imaging Study of Polyvascular Disease
Not yet recruiting
- Polyvascular Disease
- Magnetic Resonance Angiography, Ocular OCTA, CT Angiography
-
Harbin, Heilongjiang, ChinaThe Second Affiliated Hospital of Harbin Medical University
Aug 28, 2023
Tremor, Essential, Parkinson's Disease Trial in New York (Automatic DRT/VIM target-recognition method using MR-SISET and ML
Recruiting
- Tremor, Essential
- Parkinson's Disease
- Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches
- Routine clinical MRI protocol
-
New York, New YorkNYU Langone
Nov 12, 2021
CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic
Recruiting
- Central Nervous System Neoplasm
- +2 more
- Ferumoxytol
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 2, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- SBI-100 Ophthalmic Emulsion, 0.5%
- +2 more
-
Glendale, California
- +2 more
Nov 17, 2023
Neurocognitive Disorders, Post Operative Delirium, Pain Trial in Nykøbing Falster (Patient reported ourcomes)
Recruiting
- Neurocognitive Disorders
- +16 more
- Patient reported ourcomes
-
Nykøbing Falster, DenmarkNykøbing Falster Hospital
Feb 28, 2023
Asthma Copd Trial in France (MRI)
Recruiting
- Asthma Copd
- MRI
-
Bayonne, France
- +5 more
May 12, 2022
Substance Abuse, HIV Trial (electronic screening and brief intervention., Men's Health Project (MHP))
Not yet recruiting
- Substance Abuse
- HIV
- electronic screening and brief intervention.
- Men's Health Project (MHP)
- (no location specified)
Sep 13, 2022
Breast Tumor Female, Breast Cancer Trial in Orlando, Bronx, Milwaukee (Aminolevulinic Acid Hydrochloride, Eagle V1.2 Imaging
Recruiting
- Breast Neoplasm Female
- Breast Cancer
- Aminolevulinic Acid Hydrochloride
- +2 more
-
Orlando, Florida
- +2 more
Aug 29, 2022
Head and Neck Squamous Cell Carcinoma, Magnetic Resonance Imaging, Neoadjuvant Therapy Trial in Guangzhou
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Jul 27, 2023